Literature DB >> 18004731

A Delphi survey of the views of adult male patients with personality disorders on psychoeducation and social problem-solving therapy.

Mary McMurran1, Rebekah Wilmington.   

Abstract

BACKGROUND: Psychoeducation and social problem-solving therapy are treatment components that work well in tandem for offenders with personality disorders, hence it is worthwhile to maintain and improve their effectiveness. AIM: The aim was to seek patients' views of these therapies to contribute to their development.
METHOD: A Delphi survey was conducted with all 12 male inpatients of a personality disorder hospital treatment unit.
RESULTS: Round 1 produced 30 statements for psychoeducation and 59 for social problem-solving therapy to be rated in Round 2. There was consensus at a level of 70% for all items. Both psychoeducation and social problem-solving therapies were viewed as useful by these patients. The men also suggested improvements in psychoeducation, including minimizing the delay between assessment and feedback, provision of reference material, preparation for the work and support afterwards. Areas identified for improvement in social problem-solving therapy included more frequent review of progress, greater consistency of delivery, eliciting problems more effectively, providing reference material, supporting patients in group work, and the development of an advanced therapy. DISCUSSION: A Delphi approach to evaluation of therapies with the people receiving them is not only feasible but seems to offer a practical way of making useful clinical adjustments to the work. Further research with larger samples might usefully focus on whether such an approach enhances treatment compliance. 2007 John Wiley & Sons, Ltd

Entities:  

Mesh:

Year:  2007        PMID: 18004731     DOI: 10.1002/cbm.663

Source DB:  PubMed          Journal:  Crim Behav Ment Health        ISSN: 0957-9664


  1 in total

1.  Psycho-education with problem solving (PEPS) therapy for adults with personality disorder: a pragmatic multi-site community-based randomised clinical trial.

Authors:  Mary McMurran; Mike J Crawford; Joseph G Reilly; Paul McCrone; Paul Moran; Hywel Williams; Clive E Adams; Conor Duggan; Juan Delport; Diane Whitham; Florence Day
Journal:  Trials       Date:  2011-08-24       Impact factor: 2.279

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.